---
title: "Candel Therapeutics (CADL.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/CADL.US/norm.md"
symbol: "CADL.US"
name: "Candel Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/CADL.US.md"
datetime: "2026-05-20T10:16:08.673Z"
locales:
  - [en](https://longbridge.com/en/quote/CADL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CADL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CADL.US/norm.md)
---

# Candel Therapeutics (CADL.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1421 | -0.5373 | -0.2053 | -0.0931 | 0.1300 |
| ROE | -37.32% | -178.70% | -52.93% | -23.27% | 41.87% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -8.86M | -29.50M | -11.27M | -4.80M | 7.38M |
| 营业利润 | -16.28M | -15.74M | -13.21M | -11.18M | -8.13M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 201.92M | 125.19M | 93.60M | 105.97M | 95.91M |
| 权益乘数 | 1.46 | 2.41 | 1.17 | 1.17 | 1.28 |
| 每股净资产 | 1.88 | 0.9458 | 1.46 | 1.64 | 1.52 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 194.83M | 119.73M | 86.96M | 100.69M | 92.17M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 3.64M | 3.30M | 3.11M | 2.05M | 2.43M |
| 净债务 | -145.56M | -70.70M | -79.76M | -92.35M | -81.25M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -18.04M | -10.57M | -10.24M | -8.89M | -8.62M |
| 投资现金流 | -675000.00 | -409000.00 | -117000.00 | -31000.00 | -3000.00 |
| 融资现金流 | 93.81M | 43.90M | -3.37M | 17.44M | -1.87M |
| 自由现金流 | -12.47M | -5.00M | -8.44M | -10.56M | -21.11M |
| 现金流充裕率 | -2672.15% | -227.66% | -387.14% | -351.28% | -344.23% |
| 举债与偿债 | - | 47.95M | - | - | - |
| 资本支出 | -675000.00 | -409000.00 | -144000.00 | -31000.00 | -3000.00 |